Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 528

1.

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update.

Key NS, Khorana AA, Kuderer NM, Bohlke K, Lee AYY, Arcelus JI, Wong SL, Balaban EP, Flowers CR, Francis CW, Gates LE, Kakkar AK, Levine MN, Liebman HA, Tempero MA, Lyman GH, Falanga A.

J Clin Oncol. 2019 Aug 5:JCO1901461. doi: 10.1200/JCO.19.01461. [Epub ahead of print]

PMID:
31381464
2.

Patient and caregiver perceptions of lymphoma care and research opportunities: A qualitative study.

Payne JB, Dance KV, Farone M, Phan A, Ho CD, Gutierrez M, Chen L, Flowers CR.

Cancer. 2019 Jul 29. doi: 10.1002/cncr.32401. [Epub ahead of print]

PMID:
31355929
3.

Insurance status impacts overall survival in Burkitt lymphoma.

Goldstein JS, Switchenko JM, Behera M, Flowers CR, Koff JL.

Leuk Lymphoma. 2019 Jul 5:1-10. doi: 10.1080/10428194.2019.1623884. [Epub ahead of print]

PMID:
31274033
4.

Autograft vs Allograft Comparison in Pediatric Medial Patellofemoral Ligament Reconstruction.

Hendawi T, Godshaw B, Flowers C, Stephens I, Haber L, Waldron S.

Ochsner J. 2019 Summer;19(2):96-101. doi: 10.31486/toj.18.0081.

5.

Maximizing the effectiveness of oral therapies in lymphoid cancers: research gaps and unmet needs.

Zackon AYL, Ayers AA, Yeager KA, Somma ML, Friedberg JW, Flowers CR, Nastoupil LJ.

Leuk Lymphoma. 2019 Jun 4:1-9. doi: 10.1080/10428194.2019.1594217. [Epub ahead of print]

PMID:
31164024
6.

Pathogen Molecular Pattern Receptor Agonists: Treating Cancer by Mimicking Infection.

Aleynick M, Svensson-Arvelund J, Flowers CR, Marabelle A, Brody JD.

Clin Cancer Res. 2019 May 23. doi: 10.1158/1078-0432.CCR-18-1800. [Epub ahead of print] Review.

PMID:
31123052
7.

White matter microstructural properties in bipolar disorder in relationship to the spatial distribution of lithium in the brain.

Necus J, Sinha N, Smith FE, Thelwall PE, Flowers CJ, Taylor PN, Blamire AM, Cousins DA, Wang Y.

J Affect Disord. 2019 Jun 15;253:224-231. doi: 10.1016/j.jad.2019.04.075. Epub 2019 Apr 18.

8.

Racial and Socioeconomic Disparities in Mantle Cell Lymphoma.

Shah NN, Xi Y, Liu Y, Koff JL, Flowers CR, Behera M, Cohen JB.

Clin Lymphoma Myeloma Leuk. 2019 Jun;19(6):e312-e320. doi: 10.1016/j.clml.2019.03.006. Epub 2019 Mar 12.

PMID:
31029647
9.

Promoting Inuit health through a participatory whiteboard video.

Saini M, Roche S, Papadopoulos A, Markwick N, Shiwak I, Flowers C, Wood M, Edge VL, Ford J; Rigolet Inuit Community Government; Nunatsiavut Government; IHACC Research Team, Wright C, Harper SL.

Can J Public Health. 2019 Apr 25. doi: 10.17269/s41997-019-00189-1. [Epub ahead of print]

PMID:
31025298
10.

Clinical impact of Internet-based tools to guide therapeutic decisions for mantle cell lymphoma.

Gopalsamy SN, Rosenthal KM, Ayers AA, Goy A, Leonard JP, Vose JM, Obholz KL, Armitage JO, Flowers CR.

Leuk Lymphoma. 2019 Mar 8:1-9. doi: 10.1080/10428194.2019.1574006. [Epub ahead of print]

PMID:
30848966
11.

Reply to M.A. Slavin et al.

Taplitz RA, Kennedy EB, Flowers CR.

J Clin Oncol. 2019 May 1;37(13):1140-1141. doi: 10.1200/JCO.18.02227. Epub 2019 Mar 7. No abstract available.

PMID:
30844317
12.

Imaging Assessment of Partial Liquid Ventilation in Bronchopulmonary Dysplasia.

Degnan AJ, Zhu X, Flowers C, Fox WW, Zhang H, Saul D.

Curr Probl Diagn Radiol. 2019 May - Jun;48(3):247-250. doi: 10.1067/j.cpradiol.2018.12.005. Epub 2018 Dec 7.

PMID:
30738593
13.

Residential ambient benzene exposure in the United States and subsequent risk of hematologic malignancies.

Teras LR, Diver WR, Deubler EL, Krewski D, Flowers CR, Switchenko JM, Gapstur SM.

Int J Cancer. 2019 Feb 9. doi: 10.1002/ijc.32202. [Epub ahead of print]

PMID:
30737780
14.

PET-derived tumor metrics predict DLBCL response and progression-free survival.

Islam P, Goldstein J, Flowers CR.

Leuk Lymphoma. 2019 Aug;60(8):1965-1971. doi: 10.1080/10428194.2018.1562181. Epub 2019 Feb 4.

PMID:
30714446
15.

Tolerability and activity of ublituximab, umbralisib, and ibrutinib in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: a phase 1 dose escalation and expansion trial.

Nastoupil LJ, Lunning MA, Vose JM, Schreeder MT, Siddiqi T, Flowers CR, Cohen JB, Burger JA, Wierda WG, O'Brien S, Sportelli P, Miskin HP, Purdom MA, Weiss MS, Fowler NH.

Lancet Haematol. 2019 Feb;6(2):e100-e109. doi: 10.1016/S2352-3026(18)30216-3.

PMID:
30709431
16.

A population-based multistate model for diffuse large B-cell lymphoma-specific mortality in older patients.

Çağlayan Ç, Goldstein JS, Ayer T, Rai A, Flowers CR.

Cancer. 2019 Jun 1;125(11):1837-1847. doi: 10.1002/cncr.31981. Epub 2019 Feb 1.

17.

Influenza Vaccination Documentation Rates During the First Year After Diagnosis of Diffuse Large B Cell Lymphoma.

Chang A, Payne JB, Allen PB, Koff JL, Ahmed R, Flowers CR, Bednarczyk RA.

Clin Lymphoma Myeloma Leuk. 2019 Apr;19(4):239-243. doi: 10.1016/j.clml.2018.12.018. Epub 2019 Jan 2.

PMID:
30686773
18.

Assessing the Effectiveness of Treatment Sequences for Older Patients With High-risk Follicular Lymphoma With a Multistate Model.

Çağlayan Ç, Terawaki H, Ayer T, Goldstein JS, Rai A, Chen Q, Flowers C.

Clin Lymphoma Myeloma Leuk. 2019 May;19(5):300-309.e5. doi: 10.1016/j.clml.2018.12.019. Epub 2019 Jan 3.

19.

Microsimulation Modeling in Oncology.

Çağlayan Ç, Terawaki H, Chen Q, Rai A, Ayer T, Flowers CR.

JCO Clin Cancer Inform. 2018 Dec;2:1-11. doi: 10.1200/CCI.17.00029.

20.

Identifying and Addressing Disparities in Survival Outcomes for Rural Patients With Cancer.

McCullough LE, Flowers CR.

JAMA Netw Open. 2018 Aug 3;1(4):e181243. doi: 10.1001/jamanetworkopen.2018.1243. No abstract available.

PMID:
30646109
21.

Informatics Approaches to Address New Challenges in the Classification of Lymphoid Malignancies.

Jordan J, Goldstein JS, Jaye DL, Gurcan M, Flowers CR, Cooper LAD.

JCO Clin Cancer Inform. 2018;2. doi: 10.1200/CCI.17.00039. Epub 2018 Feb 9.

22.

Rural and urban patients with diffuse large B-cell and follicular lymphoma experience reduced overall survival: a National Cancer DataBase study.

Ritter AJ, Goldstein JS, Ayers AA, Flowers CR.

Leuk Lymphoma. 2019 Jul;60(7):1656-1667. doi: 10.1080/10428194.2018.1546855. Epub 2019 Jan 11.

PMID:
30632824
23.

Clinical Implications of Febrile Neutropenia Guidelines in the Cancer Patient Population.

Braga CC, Taplitz RA, Flowers CR.

J Oncol Pract. 2019 Jan;15(1):25-26. doi: 10.1200/JOP.18.00718. No abstract available.

PMID:
30629901
24.

Reply to H.J.A. Adams et al.

Shi Q, Flowers CR.

J Clin Oncol. 2019 Feb 20;37(6):526-527. doi: 10.1200/JCO.18.02022. Epub 2018 Dec 28. No abstract available.

PMID:
30592641
25.

Oligoclonal T Cells Transiently Expand and Express Tim-3 and PD-1 Following Anti-CD19 CAR T Cell Therapy: A Case Report.

Funk CR, Petersen CT, Jagirdar N, Ravindranathan S, Jaye DL, Flowers CR, Langston A, Waller EK.

Int J Mol Sci. 2018 Dec 19;19(12). pii: E4118. doi: 10.3390/ijms19124118.

26.

Intrathecal Central Nervous System Prophylaxis in Patients With Diffuse Large B-cell Lymphoma at an Academic Healthcare System.

Hall KH, Valla K, Flowers CR, Cohen JB.

Clin Lymphoma Myeloma Leuk. 2019 Feb;19(2):89-94. doi: 10.1016/j.clml.2018.11.014. Epub 2018 Nov 17.

PMID:
30528416
27.

Semantic category priming from the groundside of objects shown in nontarget locations and at unpredictable times.

Flowers CS, Peterson MA.

J Vis. 2018 Dec 3;18(13):3. doi: 10.1167/18.13.3.

PMID:
30508428
28.

Novel immunotherapy approaches to follicular lymphoma.

Flowers CR, Leonard JP, Nastoupil LJ.

Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):194-199. doi: 10.1182/asheducation-2018.1.194. Review.

PMID:
30504310
29.

Sequencing of therapies in relapsed follicular lymphoma.

Nastoupil LJ, Flowers CR, Leonard JP.

Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):189-193. doi: 10.1182/asheducation-2018.1.189. Review.

PMID:
30504309
30.

Where to start? Upfront therapy for follicular lymphoma in 2018.

Leonard JP, Nastoupil LJ, Flowers CR.

Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):185-188. doi: 10.1182/asheducation-2018.1.185. Review.

PMID:
30504308
31.

Safety and survival outcomes for bloodless transplantation in patients with myeloma.

Joseph NS, Kaufman JL, Boise LH, Valla K, Almaula DK, Obidike CO, Langston AA, Waller EK, Khoury HJ, Flowers CR, Graiser M, Heffner LT, Lonial S, Nooka AK.

Cancer. 2019 Jan 15;125(2):185-193. doi: 10.1002/cncr.31677. Epub 2018 Nov 27. Review.

PMID:
30480777
32.

What Can Cost-Effectiveness Analysis Tell Us About Chimeric Antigen Receptor T-Cell Therapy for Relapsed Acute Lymphoblastic Leukemia?

Flowers CR, Ramsey SD.

J Clin Oncol. 2018 Oct 2:JCO2018793570. doi: 10.1200/JCO.2018.79.3570. [Epub ahead of print] No abstract available.

PMID:
30277825
33.

Efficacy of salvage chemotherapy in diffuse large B cell lymphoma with primary treatment failure according to putative cell of origin.

Badar T, Hamadani M, Bachanova V, Maddocks KJ, Umyarova E, Chavez JC, Epperla N, Chhabra S, Xavier AC, Karmali R, Salhab M, Reddy N, Glenn MJ, Hernandez-Ilizaliturri FJ, Flowers CR, Evens AM, Zhou Z, Lansigan F, Barta SK, Cohen JB, Fenske TS, Costa LJ.

Leuk Lymphoma. 2019 Apr;60(4):940-946. doi: 10.1080/10428194.2018.1515944. Epub 2018 Oct 2.

PMID:
30277110
34.

Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: the phase II GATHER study.

Sharman JP, Forero-Torres A, Costa LJ, Flinn IW, Inhorn L, Kelly K, Bessudo A, Fayad LE, Kaminski MS, Evens AM, Flowers CR, Sahin D, Mundt KE, Sandmann T, Fingerle-Rowson G, Vignal C, Mobasher M, Zelenetz AD.

Leuk Lymphoma. 2019 Apr;60(4):894-903. doi: 10.1080/10428194.2018.1515940. Epub 2018 Oct 2.

PMID:
30277102
35.

The association of physical activity before and after lymphoma diagnosis with survival outcomes.

Pophali PA, Ip A, Larson MC, Rosenthal AC, Maurer MJ, Flowers CR, Link BK, Farooq U, Feldman AL, Allmer C, Slager SL, Witzig TE, Habermann TM, Cohen JB, Cerhan JR, Thompson CA.

Am J Hematol. 2018 Dec;93(12):1543-1550. doi: 10.1002/ajh.25288. Epub 2018 Oct 17.

PMID:
30230581
36.

Decreased Food and Water Intake Attributable to Failing Sanitation in the United States.

Flowers CC.

Am J Public Health. 2018 Oct;108(10):1269. doi: 10.2105/AJPH.2018.304688. No abstract available.

PMID:
30207775
37.

Reply to J.A. Talcott.

Taplitz RA, Kennedy EB, Flowers CR.

J Clin Oncol. 2018 Sep 4:JCO2018793141. doi: 10.1200/JCO.2018.79.3141. [Epub ahead of print] No abstract available.

PMID:
30179568
38.

Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update.

Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK, Langston AA, Nastoupil LJ, Rajotte M, Rolston KV, Strasfeld L, Flowers CR.

J Clin Oncol. 2018 Oct 20;36(30):3043-3054. doi: 10.1200/JCO.18.00374. Epub 2018 Sep 4.

PMID:
30179565
39.

Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update Summary.

Taplitz RA, Kennedy EB, Flowers CR.

J Oncol Pract. 2018 Sep 4:JOP1800366. doi: 10.1200/JOP.18.00366. [Epub ahead of print] No abstract available.

PMID:
30179525
40.

A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell Lymphoma.

Yazbeck V, Shafer D, Perkins EB, Coppola D, Sokol L, Richards KL, Shea T, Ruan J, Parekh S, Strair R, Flowers C, Morgan D, Kmieciak M, Bose P, Kimball A, Badros AZ, Baz R, Lin HY, Zhao X, Reich RR, Tombes MB, Shrader E, Sankala H, Roberts JD, Sullivan D, Grant S, Holkova B.

Clin Lymphoma Myeloma Leuk. 2018 Sep;18(9):569-575.e1. doi: 10.1016/j.clml.2018.05.023. Epub 2018 Jun 6.

PMID:
30122201
41.

Incidence and outcomes of lymphoid malignancies in adolescent and young adult patients in the United States.

Blum KA, Keller FG, Castellino S, Phan A, Flowers CR.

Br J Haematol. 2018 Nov;183(3):385-399. doi: 10.1111/bjh.15532. Epub 2018 Aug 10.

PMID:
30095154
42.

Clusterin from human clinical tear samples: Positive correlation between tear concentration and Schirmer strip test results.

Yu V, Bhattacharya D, Webster A, Bauskar A, Flowers C, Heur M, Chintala SK, Itakura T, Wilson MR, Barr JT, Jeong S, Wang M, Fini ME.

Ocul Surf. 2018 Oct;16(4):478-486. doi: 10.1016/j.jtos.2018.08.001. Epub 2018 Aug 2.

43.

History of autoimmune conditions and lymphoma prognosis.

Kleinstern G, Maurer MJ, Liebow M, Habermann TM, Koff JL, Allmer C, Witzig TE, Nowakowski GS, Micallef IN, Johnston PB, Inwards DJ, Thompson CA, Feldman AL, Link BK, Flowers C, Slager SL, Cerhan JR.

Blood Cancer J. 2018 Aug 1;8(8):73. doi: 10.1038/s41408-018-0105-4.

44.

Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study.

de Vos S, Swinnen LJ, Wang D, Reid E, Fowler N, Cordero J, Dunbar M, Enschede SH, Nolan C, Petrich AM, Ross JA, Salem AH, Verdugo M, Agarwal S, Zhou L, Kozloff M, Nastoupil LJ, Flowers CR.

Ann Oncol. 2018 Sep 1;29(9):1932-1938. doi: 10.1093/annonc/mdy256.

45.

Disparities in survival by insurance status in follicular lymphoma.

Goldstein JS, Nastoupil LJ, Han X, Jemal A, Ward E, Flowers CR.

Blood. 2018 Sep 13;132(11):1159-1166. doi: 10.1182/blood-2018-03-839035. Epub 2018 Jul 24.

PMID:
30042094
46.

Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Diffuse Large B-Cell Lymphoma: An Individual Patient-Level Analysis of Multiple Randomized Trials (SEAL).

Shi Q, Schmitz N, Ou FS, Dixon JG, Cunningham D, Pfreundschuh M, Seymour JF, Jaeger U, Habermann TM, Haioun C, Tilly H, Ghesquieres H, Merli F, Ziepert M, Herbrecht R, Flament J, Fu T, Coiffier B, Flowers CR.

J Clin Oncol. 2018 Sep 1;36(25):2593-2602. doi: 10.1200/JCO.2018.77.9124. Epub 2018 Jul 5.

47.

How to Decide Which DLBCL Patients Should Receive CNS Prophylaxis.

Hall KH, Panjic EH, Valla K, Flowers CR, Cohen JB.

Oncology (Williston Park). 2018 Jun;32(6):303-9. Review.

48.

Deferred treatment is a safe and viable option for selected patients with mantle cell lymphoma.

Calzada O, Switchenko JM, Maly JJ, Blum KA, Grover N, Mathews S, Park SI, Gordon M, Danilov A, Epperla N, Fenske TS, Hamadani M, Flowers CR, Cohen JB.

Leuk Lymphoma. 2018 Dec;59(12):2862-2870. doi: 10.1080/10428194.2018.1455973. Epub 2018 Jun 18.

PMID:
29912594
49.

The need to assess financial adverse events.

Nastoupil LJ, Prasad V, Flowers CR.

Lancet Haematol. 2018 Nov;5(11):e508-e509. doi: 10.1016/S2352-3026(18)30072-3. Epub 2018 Jun 12. No abstract available.

PMID:
29907551
50.

Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials.

Maurer MJ, Habermann TM, Shi Q, Schmitz N, Cunningham D, Pfreundschuh M, Seymour JF, Jaeger U, Haioun C, Tilly H, Ghesquieres H, Merli F, Ziepert M, Herbrecht R, Flament J, Fu T, Flowers CR, Coiffier B.

Ann Oncol. 2018 Aug 1;29(8):1822-1827. doi: 10.1093/annonc/mdy203.

Supplemental Content

Loading ...
Support Center